Dr John Hung
Consultant Cardiologist
Contact Details
Personal Assistant
Paula Walker
0151 600 1657
Responsibilities at LHCH
- Consultant Interventional Cardiologist
Area of Practice
- Interventional cardiology
Special Clinical Interests
- Specialist in complex coronary intervention, intracoronary imaging, chronic total occlusion (CTO) PCI
Research Interests
- PhD in cardiovascular science
Current Membership of Professional Regional and National Bodies
- British Cardiac Intervention Society
- Royal College of Physicians Edinburgh
Languages Spoken
- English, French
Why choose LHCH?
LHCH offers an internationally renowned service in percutaneous coronary intervention. We specialise in minimally invasive management of coronary artery disease, delivering world class care with cutting edge technologies.
Training and Education
- MBChB University of Liverpool
- PhD University of Edinburgh
- MRCP (UK) Edin
- Complex coronary intervention training St George’s Hospital London
About Dr Hung
Dr Hung is an interventional cardiologist specialising in complex coronary intervention and chronic total occlusion (CTO) PCI. He graduated with MBChB from the University of Liverpool, before undertaking specialist training in general cardiology and coronary intervention in Liverpool, Edinburgh, Glasgow, London and Australia.
He is an internationally renowned educator and leader in the field of complex coronary intervention, delivering global courses, conferences and webinars. Research interests include cellular mechanisms of coronary atherosclerosis, myocardial infarction, biomarkers of heart disease and radiation safety. He is multiply published and read cardiovascular science at the University of Edinburgh during his PhD.
Personally he competes regularly in road bike racing, is an ex national karate champion and a regular at Goodison Park.
He and the complex coronary intervention team at LHCH are at the heart of education, research and innovation in cardiac intervention.
Relevant Publications
|
Hung JD, Spratt JC. Antegrade CTO Techniques. Interventional Cardiology: Reviews, Research, Resources 2022 |
|
Hung JD, Brugaletta S, Spratt JC. The Future of Individualised Cardiovascular Care: How Wearables Could be Integrated to Improve Outcomes. Eur Heart J. 2022 – In Press |
|
Hung J, Bularga A, Daghem M, Stewart S, Taggart C, Wereski R, et al. Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study. Circulation. 2022. |
|
Hung J, Roos A, Kadesjo E, McAllister DA, Kimenai DM, Shah ASV, et al. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction. Eur Heart J. 2021;42(26):2552-61. |
|
Spratt JC, Hung JD. In-stent CTOs: same story with a different conclusion? EuroIntervention. 2021;17(8):e611-e2. |
|
Hung J, Giblett JP. Iatrogenic Aortocoronary Dissection During Percutaneous Coronary Intervention: Investigation and Management. JACC Case Rep. 2021;3(1):1-5. |
|
Hung J, Scanlon JP, Mahmoud AD, Rodor J, Ballantyne M, Fontaine MAC, et al. Novel Plaque Enriched Long Noncoding RNA in Atherosclerotic Macrophage Regulation (PELATON). Arterioscler Thromb Vasc Biol. 2020;40(3):697-713. |
|
Chapman AR, Adamson PD, Shah ASV, Anand A, Strachan FE, Ferry AV, et al. High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. Circulation. 2020;141(3):161-71. |
|
Lee KK, Ferry AV, Anand A, Strachan FE, Chapman AR, Kimenai DM, et al. Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome. J Am Coll Cardiol. 2019;74(16):2032-43. |
|
Hung J, Miscianinov V, Sluimer JC, Newby DE, Baker AH. Targeting Non-coding RNA in Vascular Biology and Disease. Front Physiol. 2018;9:1655. |